| Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions CB Poulsen, AL Al-Mashhadi, K von Wachenfeldt, JF Bentzon, LB Nielsen, ... International Journal of Cardiology 215, 506-515, 2016 | 28 | 2016 |
| Local pressure drives low-density lipoprotein accumulation and coronary atherosclerosis in hypertensive minipigs RH Al-Mashhadi, AL Al-Mashhadi, ZP Nasr, MB Mortensen, EA Lewis, ... Journal of the American College of Cardiology 77 (5), 575-589, 2021 | 21 | 2021 |
| Diet-induced abdominal obesity, metabolic changes, and atherosclerosis in hypercholesterolemic minipigs AL Al-Mashhadi, CB Poulsen, K von Wachenfeldt, AK Robertson, ... Journal of diabetes research 2018, 2018 | 20 | 2018 |
| Mental health among patients with non‐Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators AK Øvlisen, LH Jakobsen, KH Kragholm, RE Nielsen, P de Nully Brown, ... American Journal of Hematology 97 (6), 749-761, 2022 | 7 | 2022 |
| Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP (− like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group A Ludvigsen Al‐Mashhadi, H Cederleuf, R Kuhr Jensen, T Holm Nielsen, ... American Journal of Hematology 98 (3), 388-397, 2023 | 5 | 2023 |
| Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models J Jelicic, K Juul-Jensen, Z Bukumiric, M Roost Clausen, ... Blood Cancer Journal 13 (1), 157, 2023 | 3 | 2023 |
| Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas AL AL‐Mashhadi, LH Jakobsen, P Brown, AO Gang, AL Thorsteinsson, ... British Journal of Haematology 204 (3), 839-848, 2024 | 1 | 2024 |
| VEXAS syndrome as a cause of debilitating fatigue and intermittent fever. M Alkattan, AL Al-Mashhadi, MS Ettrup, L Dreyer Ugeskrift for Laeger 185 (8), V10220643-V10220643, 2023 | 1 | 2023 |
| Mental Health Among Patients with Non-Hodgkin Lymphoma: A Danish Nationwide Study of Psychotropic Drug Use in 7,201 Patients and 36,005 Matched Comparators AK Øvlisen, LH Jakobsen, KH Kragholm, RE Nielsen, PDN Brown, ... Blood 138, 51, 2021 | 1 | 2021 |
| In Vivo High Resolution Isotropic 3D MRI of Coronary Atherosclerosis in Hypertensive Hypercholesterolemic Minipigs RH Al-Mashhadi, ES Hansen, L Bloch, AH Al-Mashhadi, S Ringgaard, ... Circulation 130 (suppl_2), A17809-A17809, 2014 | 1 | 2014 |
| Favorable Outcomes of Splenic Marginal Zone Lymphoma in an International Study of 934 Patients with Long Follow-up AL Al-Mashhadi, MRR Simonsen, CY Cheah, RM Amini, B Arboe, ... Blood 142, 4396, 2023 | | 2023 |
| An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma Y Wang, MC Larson, U Farooq, S Ekberg, KE Smedby, MR Simonsen, ... Blood 142, 1656, 2023 | | 2023 |
| A Population-Based Study on Performance of Clinical Prognostic Models in Patients with Diffuse Large B-Cell Lymphoma Younger Than 70 Years J Jelicic, K Juul-Jensen, Z Bukumiric, MR Clausen, AL Al-Mashhadi, ... Blood 142, 190, 2023 | | 2023 |
| DreyerVEXAS-syndrom som årsag til invaliderende træthed og intermitterende feber M Alkattan, AL Al-Mashhadi, MS Ettrup, L Dreyer Ugeskrift for laeger 185 (6), 539-540, 2023 | | 2023 |
| VEXAS-syndrom som årsag til invaliderende træthed og intermitterende træthed og intermitterende feber M Alkattan, AL Al-Mashhadi, MS Ettrup, L Dreyer Ugeskr Læger 185, V10220643, 2023 | | 2023 |
| Outcome after 3rd Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study A Ludvigsen Al-Mashhadi, LH Jakobsen, PN Brown, A Ortved Gang, ... Blood 140 (Supplement 1), 6706-6707, 2022 | | 2022 |
| Imatinib-Induced Interstitial Lung Disease: A Case Report AL Al-Mashhadi, J Stentoft, AS Roug Austin Hematology 3 (1), 1-3, 2018 | | 2018 |
| REPLY: Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing CB Poulsen, AL Al-Mashhadi, JF Bentzon, E Falk International Journal of Cardiology 229, 8, 2017 | | 2017 |
